SpyGlass Pharma is pursuing a $100 million IPO to advance its glaucoma drug delivery platform through Phase 3 trials. Read ...

Under the FDA-authorized expanded access (IND 176297), urcosimod is being provided by OKYO Pharma for use in a patient with severe neuropathic corneal pain who has limited therapeutic options and no ...

OMAHA, NE - January 22, 2026 - PRESSADVANTAGE - Modern Vision Solutions has announced the publication of a new article, ...

How Effective Are Eye Creams , at Treating Wrinkles?. Doctors say that wrinkles around the eyes are common because of the ...

Purpose Since first being introduced over 50 years ago, ophthalmic viscoelastic devices (OVDs) have revolutionised the fields ...